Brooks Automation Announces The Acquisition Of Cool Lab, LLC

CHELMSFORD, Mass., Nov. 29, 2016 (GLOBE NEWSWIRE) -- Brooks Automation, Inc. (Nasdaq:BRKS) announced today that it has acquired Cool Lab, LLC, a subsidiary of BioCision, LLC.  Cool Lab provides a range of innovative, patented, and/or patent-pending applications for sample cooling and freezing, controlled rate freezing, portable cryogenic transport and archival storage solutions for customers' temperature sensitive workflows.  The offerings address and assist in managing the temperature stability of therapeutics, biological samples, and related biomaterials in ultra-cold and cryogenic environments. 

BioCision is a highly regarded innovator of products that standardize biomaterial sample handling to increase the successful outcomes of research, clinical and therapeutic discovery and development.   Brooks Automation has held an equity interest in BioCision since 2014 and subsequently supported the business with convertible debt and term note financing.  Through this relationship, BioCision and Brooks collaborated in the development of advanced solutions in temperature control including the CryoPod™ personal mobile carrier capable of maintaining cryogenic temperatures for more than four hours.   This and other sample management lab products were transferred into Cool Lab, a subsidiary of BioCision.  Corning Life Sciences will continue to be the global distributor of the innovative CoolCell® cell cryopreservation systems, CoolBox™ ice-free sample preparation systems, CoolRack® systems, and other associated products.  The Cool Lab product line includes the CryoPod™ and the suite of products distributed by Corning.

"This acquisition is a successful outcome from our long partnership with BioCision," stated Dusty Tenney, president, Brooks Life Science Systems.  "The product line extends our range of comprehensive sample management solutions that provide sample integrity, quality and utility across the cold chain of custody for our customers."

"Brooks has been a great business partner for the last two years, and their acquisition of the BioCision Cool Lab business highlights the extent of our joint collaboration and developments," said Rolf Ehrhardt, MD, PhD, chief executive officer, BioCision.  Dr. Ehrhardt added, "Our strategic relationship was driven by a focus on innovative products and the growing customer needs for improved sample management workflows."

If you liked this article you might like

Amgen, Brooks Automation, Alaska Air: 'Mad Money' Lightning Round May 1

Apple, Facebook, Netflix Flying High: Cramer's 'Mad Money' Recap (Monday 5/1/17)

Bigger Upside Move Seen for Brooks Automation

Bigger Upside Move Seen for Brooks Automation

'Mad Money' Lightning Round: Buy, Buy, Buy Home Depot

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week